Introduction Virtual reality-based telerehabilitation (VR-TR) combines gamified exercises with remote supervision for people with Parkinson’s disease (PD). Its effectiveness and safety in PD remain ...
Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...
Essential tremor is a neurological condition which causes involuntary trembling - most commonly in the hands and arms, but ...
GOING TO BE VERY MILD. I’LL HAVE THAT FOR YOU COMING UP. ALL RIGHT. THANKS, MO. A GROUNDBREAKING TREATMENT FOR PARKINSON’S AND TREMORS IS NOW AVAILABLE IN KENTUCKY. THE NORTON NEUROSCIENCE INSTITUTE ...
Everyday Health on MSN
How to Manage Anxiety in Advanced Parkinson's Disease
Learn to manage anxiety in advanced Parkinson's with treatments like therapy, medication, lifestyle changes, and more to ...
(RTTNews) - Praxis Precision Medicines, Inc. (PRAX) on Monday said the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to ulixacaltamide for the treatment of patients ...
Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor. Praxis on ...
Some Parkinson’s patients may experience strange symptoms, like smell loss and sleep disorders, decades before diagnosis.
6don MSN
Scientists report new immune insights and targets into LRRK2 mutations in Parkinson's disease
Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...
BOSTON, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential tremor Praxis remains on track to submit ulixacaltamide NDA in ...
ACADIA Pharmaceuticals (NASDAQ:ACAD) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results